| Christine L Hughes, MSSW LCSW | |
|
212 11th St S, La Crosse, WI 54601-4116 | |
| (608) 392-9555 | |
| Not Available |
| Full Name | Christine L Hughes |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 23 Years |
| Location | 212 11th St S, La Crosse, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013947506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7077 (Wisconsin) | Secondary |
| 1041C0700X | Social Worker - Clinical | 29507 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Clinic Ltd | 9638082779 | 359 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.
After Congress failed in its recent attempt to cut off federal funding, lawmakers in several states are taking aim at the organization. Meanwhile, the House voted Wednesday to ban teaching health centers from using federal dollars to train physicians on how to perform abortions.
The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.
› Verified 9 days ago
| Entity Name | Gundersen Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031113000579 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.
After Congress failed in its recent attempt to cut off federal funding, lawmakers in several states are taking aim at the organization. Meanwhile, the House voted Wednesday to ban teaching health centers from using federal dollars to train physicians on how to perform abortions.
The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine L Hughes, MSSW LCSW 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 | Christine L Hughes, MSSW LCSW 212 11th St S, La Crosse, WI 54601-4116 Ph: (608) 392-9555 |
News Archive
Wall Street Journal reports: "As Washington wrestles with health-care reform, states have been busy passing their own laws to allow many young adults to remain longer on a parent's health insurance."
Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.
After Congress failed in its recent attempt to cut off federal funding, lawmakers in several states are taking aim at the organization. Meanwhile, the House voted Wednesday to ban teaching health centers from using federal dollars to train physicians on how to perform abortions.
The US Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF) marking the first approval of a new oral anticoagulant in the U.S. in more than 50 years.
› Verified 9 days ago
Christi M Nowland, MSSW LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 319 Main St Ste 510, La Crosse, WI 54601 Phone: 608-461-1785 Fax: 608-796-1114 | |
Robert E Hanson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 212 11th Avenue S., La Crosse, WI 54601 Phone: 608-392-9555 Fax: 608-392-9432 | |
Ms. Melissa Lea Thielman, MSSW, CAPSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 212 11th St S, La Crosse, WI 54601 Phone: 608-392-9555 Fax: 608-392-9432 | |
Mrs. Carol A Ogea, LISW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Ms. Nancy J Pohlman, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 605 4th St S, La Crosse, WI 54601 Phone: 608-615-1023 Fax: 608-615-1063 | |
Jon W Dickson, MS Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 123 16th St S, La Crosse, WI 54601 Phone: 608-775-8646 |